Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cellsBrain, Jul 2010; 133: 1961 - 1972
[Brain Cancer Panel I ]
Global analysis of microarray data reveals intrinsic properties in gene expression and tissue selectivityBioinformatics, Jul 2010; 26: 1723 - 1730.
[Cancer Survey Panel 384 - I ]
Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathyBrain, Jul 2010; 133: 2123 - 2135
[HSCA101]
Membrane Trafficking of Large Conductance Calcium-activated Potassium Channels Is Regulated by Alternative Splicing of a Transplantable, Acidic Trafficking Motif in the RCK1-RCK2 LinkerJ. Biol. Chem., Jul 2010; 285: 23265 - 23275
[]
TissueFocus Tissue Microarray (TMA)
Quality tissue arrays for your high-throughput molecular analysis
Tissue microarrays (TMAs) are created from high-quality tissue samples from the OriGene Tissue Biorepository, a growing collection of over >140,000 tissue samples, molecular derivatives, and associated clinical data that represent hundreds of pathology diagnoses.
Our high-quality tumor progression TMAs are produced using formalin-fixed paraffin-embedded (FFPE) tissue samples.
Collected under the highest bioethical guidelines using strict IRB-approved protocols from accredited medical institutions in the US.
Tissue samples were tracked and maintained in a rigorously monitored environment, using the most sophisticated automated biospecimen management software
Sample cores selected by board-certified pathologists.
TMA Datasheet/Map includes H&E images and detailed pathology reports with histological subtypes, and TNM staging.
Fully qualified for IHC analysis and suitable for in situ hybridization (ISH) analysis.
The following TMAs were specifically designed to match OriGene TissueScan cancer first-strand cDNA arrays. Use our TissueScan qPCR arrays to reveal gene expression profiles across disease stages, while also assessing expression of proteins with our matched TMAs below.